Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

Resultado final

Report on Communication activities carried out

List of press releases to local and national press publication on news about the project

Report on Dissemination activities carried out

List of publications of nonconfidential results

Training reports including core scientific training and transferable skills

Description of planed scientific training and transferable skills to be carried out during the project.

Scaffold hopping and database report

Results using 3D pharmacophores programs

Report on VIRO-FLOW Schools

Description of VIROFLOW Schools and actions performed

Publicaciones

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators

Autores: Tamás Vermes, Mark Kielpinski, Thomas Henkel, Miquel A. Pericàs, Esther Alza, Angelica Corcuera, Helmut Buschmann, Thomas Goldner and Andreas Urban
Publicado en: Analytical Methods, Edición 14, 2022, Página(s) 135-146, ISSN 1759-9660
Editor: Royal Society of Chemistry
DOI: 10.1039/d1ay01227d

Derechos de propiedad intelectual

NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Número de solicitud/publicación: 20 20061946
Fecha: 2020-04-29
Solicitante(s): AICURIS ANTI-INFECTIVE CURES AG

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Número de solicitud/publicación: 20 20061946
Fecha: 2020-04-29
Solicitante(s): AICURIS ANTI-INFECTIVE CURES AG

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles